Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s): QNTM

Healthcare Biotechnology

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.

CSE:QNTM - Post by User

Quantum BioPharma Ltd

Bullboard Posts

Comment by namechangeneedeon Jun 12, 2019 5:15pm

127 Views

Post# 29820016

RE:IR news update - I am sure HUGE is in Right Track

$1.00 Soon?!!?! So Huge is a $1.3 Billion dollar company when we get some financial news? You are smoking most of huge weed I think. Good grief.

MoneyStock wrote: As we get any financial news, then HUGE will be close to $1.00 soon.

Good Afternoon,

We know of no specific reason for the share weakness. We continue to focus on things we can control- scaling our operations, investing in the business, reducing our cost of capital, hiring highly qualified people, research and development, developing the facility and continue to accomplish more milestones this calendar year.

During these periods, keep in mind of the original thesis of the company and the value we have created going forward. Yes, It’s only management announcements recently but these are highly qualified doctors with outstanding track records and have joined FSD Pharma with each of their own intent to accomplish within the company. FSD Pharma’s strategic partnerships position the company to execute on several divisions of the cannabis industry:

Retail investments: High Tide & Huge Shops

Extractions: World Class Extractions

Supply agreements: Aura health to establish distribution channel in Germany & Eurozone

CBD consumption products: Canntab Therapeutic’s hard pill CBD tablet, and Pharmastrip

Research & Development: Scicann Therapeutics, Prismic Pharmaceuticals, and Solarvest

Cultivation partnership with Cannara Biotech

Best Regards,
IR FSD Pharma